HPS0769-95
41475-27-8
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS0769-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | C-Peptide 1 (rat) trifluoroacetate salt |
|---|---|
| 序列(三字母) | H-Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln-OH trifluoroacetate salt |
| 序列(单字母) | EVEDPQVPQLELGGGPEAGDLQTLALEVARQ |
| CAS# | 41475-27-8 |
| 分子式 | C₁₄₀H₂₂₈N₃₈O₅₁ |
| 分子量 | 3259.58 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Diabetes |
| 描述 | Studies of the cellular effects of C-peptide have shown that it binds specifically in a nanomolar concentration range to a G-protein coupled membrane receptor, with subsequent activation of Ca²⁺-dependent intracellular signaling pathways. This resulted in stimulation of both Na⁺-K⁺-ATPase, and endothelial nitric oxide synthase activities. Administration of C-peptide to streptozotocin induced diabetic rats elicited a substantial increase in whole-body glucose turnover. |
